Ni et al., 2015
Value-based pricing, patient support programs, and cooperation among healthcare providers, payers, and legislators may help overcome these barriers and increase access to promising drugs [111,114]
doi: 10.1038/mp.2016.44 Summary Keywords depression, glucagon-like peptide-1 (GLP-1), neuroinflammation, neurogenesis, synaptic plasticity Citation Kim Y-K, Kim OY and Song J (2020) Alleviation of Depression by Glucagon-Like Peptide 1 Through the Regulation of Neuroinflammation, Neurotransmitters, Neurogenesis, and Synaptic Function
For example, researchers conducting a long-term study on peptide-based drug candidates would prioritize storing their peptide libraries in powder form at ultra-low temperatures to maintain their efficacy over the study period
10.1210/en.2012-2124 82